Alpha 2.0
Login Register
» Articles » PMID: 7986017

Activities of the Benzoxazinorifamycin KRM 1648 and Ethambutol Against Mycobacterium Avium Complex in Vitro and in Macrophages

Overview
Journal Antimicrob Agents Chemother
Publisher American Society for Microbiology
Specialty Pharmacology
Date 1994 Aug 1
PMID 7986017
Citations 8
Authors
C B Inderlied
M Wu
L S Young
L E Bermudez
Affiliations
Soon will be listed here.
Abstract

KRM 1648 is a 4-aminobenzoxazine derivative of rifamycin S with potent in vitro activity against the Mycobacterium avium complex (MAC); the MIC for 90% of 24 MAC isolates from AIDS patients was 0.25 microgram/ml as determined by a radiometric broth macrodilution assay. KRM 1648 was bactericidal for MAC isolates in Middlebrook 7H9 broth, with a reduction in viability of 1 to 4 orders of magnitude over 72 h. In human macrophages, KRM 1648 also was bactericidal, with a reduction of 3 to 4 orders of magnitude in CFU per ml of macrophage lysate at a concentration of 1 microgram/ml; however, the bactericidal activity varied approximately 10-fold among the three MAC serovars tested. In growth medium, ethambutol potentiated the effect of KRM 1648, but this potentiation was modest when tested against MAC in macrophages and also varied between MAC strains. KRM 1648 has potential as an antimycobacterial agent for MAC disease, perhaps in combination with other agents so that the use of lower dosages of KRM 1648 than are needed with other rifamycins may be possible.

Citing Articles

Recent Biochemical Advances in Antitubercular Drugs: Challenges and Future.

Jain A, Kumar R, Mothsra P, Sharma A, Singh A, Kumar Y Curr Top Med Chem. 2024; 24(21):1829-1855.

PMID: 38919089 DOI: 10.2174/0115680266286294240610102911.

Identification of (+)-erythro-mefloquine as an active enantiomer with greater efficacy than mefloquine against Mycobacterium avium infection in mice.

Bermudez L, Inderlied C, Kolonoski P, Chee C, Aralar P, Petrofsky M Antimicrob Agents Chemother. 2012; 56(8):4202-6.

PMID: 22615290 PMC: 3421598. DOI: 10.1128/AAC.00320-12.

Effects of the Chinese traditional medicine mao-bushi-saishin-to on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice.

Shimizu T, Tomioka H, Sato K, Sano C, Akaki T, Dekio S Antimicrob Agents Chemother. 1999; 43(3):514-9.

PMID: 10049260 PMC: 89153. DOI: 10.1128/AAC.43.3.514.

Pharmacokinetics of KRM-1648, a new benzoxazinorifamycin, in rats and dogs.

Hosoe K, Mae T, Konishi E, Fujii K, Yamashita K, Yamane T Antimicrob Agents Chemother. 1996; 40(12):2749-55.

PMID: 9124834 PMC: 163615. DOI: 10.1128/AAC.40.12.2749.

Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.

Bermudez L, Inderlied C, Kolonoski P, Wu M, Young L Antimicrob Agents Chemother. 1996; 40(3):546-51.

PMID: 8851568 PMC: 163155. DOI: 10.1128/AAC.40.3.546.

References
1.
Dautzenberg B, Truffot C, Legris S, Meyohas M, Berlie H, Mercat A . Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am Rev Respir Dis. 1991; 144(3 Pt 1):564-9. DOI: 10.1164/ajrccm/144.3_Pt_1.564. View
2.
Young L, Wiviott L, Wu M, Kolonoski P, Bolan R, Inderlied C . Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet. 1991; 338(8775):1107-9. DOI: 10.1016/0140-6736(91)91965-w. View
3.
Tomioka H, Saito H, Sato K, Yamane T, Yamashita K, Hosoe K . Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice. Antimicrob Agents Chemother. 1992; 36(2):387-93. PMC: 188446. DOI: 10.1128/AAC.36.2.387. View
4.
Dautzenberg B, Saint Marc T, Meyohas M, Eliaszewitch M, Haniez F, Rogues A . Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch Intern Med. 1993; 153(3):368-72. View
5.
Tomioka H, Saito H, Fujii K, Sato K, Hidaka T . In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. Antimicrob Agents Chemother. 1993; 37(1):67-70. PMC: 187606. DOI: 10.1128/AAC.37.1.67. View